Alyeska Investment Group, L.P. Gain Therapeutics, Inc. Call Options Transaction History
Alyeska Investment Group, L.P.
- $16.5 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GANX
# of Institutions
31Shares Held
3.75MCall Options Held
0Put Options Held
0-
Timelo Investment Management Inc.605KShares$907,9320.45% of portfolio
-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$882,6150.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$849,1950.04% of portfolio
-
Hohimer Wealth Management, LLC330KShares$495,0000.1% of portfolio
-
Geode Capital Management, LLC Boston, MA184KShares$275,6040.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $17.8M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...